Summary by Futu AI
Hengrui Pharma announced on October 13, 2025, that it will convene a board meeting on October 27, 2025 (Monday). The primary agenda will include reviewing and approving the quarterly financial results of the company and its subsidiaries for the nine months ended September 30, 2025, as well as discussing matters related to the release of these results.This meeting has been convened by Chairman Sun Piaoyang. The current board members comprise six executive directors, one non-executive director, and four independent non-executive directors.